Cargando…

Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review

IMPORTANCE: Most frequent worldwide cause of permanent blindness is glaucoma. Early in the course of the disease, glaucoma affects many patients without any symptoms. In order to examine for indications of glaucoma and to ascertain whether systemic illnesses or drugs can raise a patient's risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Poonam, Dangwal, Aayush, Guleria, Itika, Kothari, Sunil, Singh, Pooja, Kalra, Jyoti M, Jakhmola, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905872/
https://www.ncbi.nlm.nih.gov/pubmed/36793264
http://dx.doi.org/10.5005/jp-journals-10078-1388
_version_ 1784883895673552896
author Joshi, Poonam
Dangwal, Aayush
Guleria, Itika
Kothari, Sunil
Singh, Pooja
Kalra, Jyoti M
Jakhmola, Vikas
author_facet Joshi, Poonam
Dangwal, Aayush
Guleria, Itika
Kothari, Sunil
Singh, Pooja
Kalra, Jyoti M
Jakhmola, Vikas
author_sort Joshi, Poonam
collection PubMed
description IMPORTANCE: Most frequent worldwide cause of permanent blindness is glaucoma. Early in the course of the disease, glaucoma affects many patients without any symptoms. In order to examine for indications of glaucoma and to ascertain whether systemic illnesses or drugs can raise a patient's risk of developing glaucoma, primary care practitioners should be aware of which patients to send to an eye care specialist. A review of the pathogenesis, risk factors, screening, disease monitoring, and treatment options for open-angle and narrow-angle glaucoma are included. OBSERVATIONS: The optic nerve and retinal nerve fiber layer (rNFL) are damaged in glaucoma, a chronic, progressive optic neuropathy that can result in a permanent loss of peripheral or central vision. The only risk factor that is known to be controllable is intraocular pressure (IOP). A family history of glaucoma, older age, and non-white race are additional significant risk factors. Numerous systemic diseases and drugs, such as corticosteroids, anticholinergics, certain antidepressants, and topiramate, can put people at risk of developing glaucoma. Open-angle and angle-closure glaucoma are the two main types of disease. Measurement of IOP, perimetry, and optical coherence tomography are diagnostic procedures to evaluate glaucoma and track the course of the condition. In order to treat glaucoma, IOP must be decreased. This is possible with a variety of glaucoma medication classes, laser surgery, and incisional surgery. VERDICTS AND RELEVANCE: By identifying systemic illnesses and drugs that raise a patient's chance of developing glaucoma and referring high-risk individuals for a thorough ophthalmologic examination, vision loss from glaucoma can be reduced. Clinicians should make sure that patients continue taking their glaucoma drugs as prescribed and should keep an eye out for any negative side effects from any medical or surgical procedures used to treat glaucoma. HOW TO CITE THIS ARTICLE: Joshi P, Dangwal A, Guleria I, et al. Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, categorizing Glaucoma's Stages: A Review. J Curr Glaucoma Pract 2022;16(3):170-178.
format Online
Article
Text
id pubmed-9905872
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-99058722023-02-14 Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review Joshi, Poonam Dangwal, Aayush Guleria, Itika Kothari, Sunil Singh, Pooja Kalra, Jyoti M Jakhmola, Vikas J Curr Glaucoma Pract Review Article IMPORTANCE: Most frequent worldwide cause of permanent blindness is glaucoma. Early in the course of the disease, glaucoma affects many patients without any symptoms. In order to examine for indications of glaucoma and to ascertain whether systemic illnesses or drugs can raise a patient's risk of developing glaucoma, primary care practitioners should be aware of which patients to send to an eye care specialist. A review of the pathogenesis, risk factors, screening, disease monitoring, and treatment options for open-angle and narrow-angle glaucoma are included. OBSERVATIONS: The optic nerve and retinal nerve fiber layer (rNFL) are damaged in glaucoma, a chronic, progressive optic neuropathy that can result in a permanent loss of peripheral or central vision. The only risk factor that is known to be controllable is intraocular pressure (IOP). A family history of glaucoma, older age, and non-white race are additional significant risk factors. Numerous systemic diseases and drugs, such as corticosteroids, anticholinergics, certain antidepressants, and topiramate, can put people at risk of developing glaucoma. Open-angle and angle-closure glaucoma are the two main types of disease. Measurement of IOP, perimetry, and optical coherence tomography are diagnostic procedures to evaluate glaucoma and track the course of the condition. In order to treat glaucoma, IOP must be decreased. This is possible with a variety of glaucoma medication classes, laser surgery, and incisional surgery. VERDICTS AND RELEVANCE: By identifying systemic illnesses and drugs that raise a patient's chance of developing glaucoma and referring high-risk individuals for a thorough ophthalmologic examination, vision loss from glaucoma can be reduced. Clinicians should make sure that patients continue taking their glaucoma drugs as prescribed and should keep an eye out for any negative side effects from any medical or surgical procedures used to treat glaucoma. HOW TO CITE THIS ARTICLE: Joshi P, Dangwal A, Guleria I, et al. Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, categorizing Glaucoma's Stages: A Review. J Curr Glaucoma Pract 2022;16(3):170-178. Jaypee Brothers Medical Publishers 2022 /pmc/articles/PMC9905872/ /pubmed/36793264 http://dx.doi.org/10.5005/jp-journals-10078-1388 Text en Copyright © 2022; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review Article
Joshi, Poonam
Dangwal, Aayush
Guleria, Itika
Kothari, Sunil
Singh, Pooja
Kalra, Jyoti M
Jakhmola, Vikas
Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
title Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
title_full Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
title_fullStr Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
title_full_unstemmed Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
title_short Glaucoma in Adults-diagnosis, Management, and Prediagnosis to End-stage, Categorizing Glaucoma's Stages: A Review
title_sort glaucoma in adults-diagnosis, management, and prediagnosis to end-stage, categorizing glaucoma's stages: a review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905872/
https://www.ncbi.nlm.nih.gov/pubmed/36793264
http://dx.doi.org/10.5005/jp-journals-10078-1388
work_keys_str_mv AT joshipoonam glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview
AT dangwalaayush glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview
AT guleriaitika glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview
AT kotharisunil glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview
AT singhpooja glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview
AT kalrajyotim glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview
AT jakhmolavikas glaucomainadultsdiagnosismanagementandprediagnosistoendstagecategorizingglaucomasstagesareview